AMENDMENT NO. 2 TO MERGER AGREEMENT AND PLAN OF REORGANIZATIONMerger Agreement • February 12th, 2013 • Epicept Corp • Pharmaceutical preparations
This Second Amendment to Merger Agreement and Plan of Reorganization (the “Second Amendment”), is made as of the 11th day of February, 2013 (the “Effective Date”), by and between Immune Pharmaceuticals Ltd. (“Immune”), EpiCept Corporation and EpiCept Israel Ltd., an Israeli company (together, “EpiCept”). Immune and Epicept shall hereinafter sometimes be referred to collectively as the “Parties”. Capitalized terms used herein and not otherwise defined shall have the respective definitions ascribed to them in the Merger Agreement and Plan of Reorganization dated November 7, 2012, as amended by the Amendment to Merger Agreement and Plan of Reorganization dated November 27, 2012 (the “First Amendment” and together, the “Merger Agreement”).
